AC Immune (ACIU) Amortization of Deferred Charges (2019 - 2025)

AC Immune (ACIU) has 7 years of Amortization of Deferred Charges data on file, last reported at $407881.4 in Q4 2025.

• On a quarterly basis, Amortization of Deferred Charges rose 110.18% year-over-year to $407881.4 in Q4 2025; TTM through Dec 2025 was $1.3 million, a 74.43% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 73.24% from the prior year.
• Amortization of Deferred Charges for Q4 2025 stood at $407881.4, up from $341279.9 in the prior quarter.
• Over the last five years, Amortization of Deferred Charges for ACIU reached as high as $407881.4 in Q4 2025 and fell as low as $118348.3 in Q1 2021.
• Historically, Amortization of Deferred Charges has averaged $195683.2 across 5 years, with a median of $154656.3 in 2021.
• Across the five-year window, Amortization of Deferred Charges retreated 5.6% in 2022 and soared 110.18% in 2025, its largest moves.
• Year by year, Amortization of Deferred Charges stood at $153999.3 in 2021, then dropped by 5.19% to $145999.4 in 2022, then rose by 6.56% to $155574.9 in 2023, then grew by 24.74% to $194058.7 in 2024, then jumped by 110.18% to $407881.4 in 2025.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $407881.4 in Q4 2025, $341279.9 in Q3 2025, and $314051.5 in Q2 2025.